...which reduces blood pressure (now, another application for Anavex 2-73).
Hypertension (high blood pressure) is a major pathology. Gigantic market.
This may be some simple question but in these last two patent examples which treatment is the (adjunctee and which one is the adjuncter)? If not BP then principal treatment must be AVXL? How will that be established?
AAND...for extraaaa credit...at what point will BP wake up and realize it is being surrounded by a tiny Biotec firm and there is nothing they can do about it. AND, is the need to reestablish Cellular Homeostasis a legitimate diagnosis for an MD to make?